ABBV vs GEHC
By Alex · Tickerpine
AbbVie Inc. vs GE HealthCare Technologies Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | GEHC |
|---|---|---|
| Price | $248.76 | $72.28 |
| Market cap | $439.59B | $32.65B |
| P/E ratio | 70.5 | 16.7 |
| ROE | — | 19.38% |
| Profit margin | 9.80% | 9.33% |
| Revenue growth | 10.20% | 5.80% |
| Dividend yield | 2.77% | 0.19% |
| Beta | 0.28 | 0.82 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs GEHC in plain English
- ABBV is the bigger company — about 13.5× the market cap of GEHC.
- GEHC is cheaper on earnings (P/E 16.7 vs 70.5).
- ABBV is growing revenue faster (10% vs 6%).
- ABBV has the higher dividend yield (2.77% vs 0.19%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
GEHC return calculator
See what $1,000 in GE HealthCare Technologies Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.